Free Trial
NASDAQ:AKAN

Akanda (AKAN) Stock Price, News & Analysis

Akanda logo
$28.30 -8.89 (-23.90%)
As of 03:09 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Akanda Stock (NASDAQ:AKAN)

Advanced

Key Stats

Today's Range
$27.00
$35.45
50-Day Range
$2.68
$48.96
52-Week Range
$2.30
$209.02
Volume
354,868 shs
Average Volume
1.67 million shs
Market Capitalization
$15.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Akanda Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

AKAN MarketRank™: 

Akanda scored higher than 20% of companies evaluated by MarketBeat, and ranked 777th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Akanda has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Akanda has only been the subject of 1 research reports in the past 90 days.

  • Read more about Akanda's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Akanda has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.04% of the float of Akanda has been sold short.
  • Short Interest Ratio / Days to Cover

    Akanda has a short interest ratio ("days to cover") of 0.72, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Akanda has recently decreased by 80.68%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Akanda does not currently pay a dividend.

  • Dividend Growth

    Akanda does not have a long track record of dividend growth.

  • News Sentiment

    Akanda has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Akanda this week, compared to 3 articles on an average week.
  • Search Interest

    51 people have searched for AKAN on MarketBeat in the last 30 days. This is an increase of 5,000% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Akanda to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Akanda insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.39% of the stock of Akanda is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    1.00% of the stock of Akanda is held by institutions.

  • Read more about Akanda's insider trading history.
Receive AKAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akanda and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AKAN Stock News Headlines

Best Cannabis Stocks To Follow Today - May 2nd
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.tc pixel
Top Cannabis Stocks To Watch Now - April 30th
Akanda Corp. Delays 20-F Amid Strategic Shift
3 Penny Stocks to Watch Now, 4/30/26
See More Headlines

AKAN Stock Analysis - Frequently Asked Questions

Akanda's stock was trading at $10.2893 at the beginning of 2026. Since then, AKAN shares have increased by 179.1% and is now trading at $28.7140.

Akanda shares reverse split before market open on Monday, April 13th 2026.The 2-9 reverse split was announced on Thursday, April 9th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 10th 2026. An investor that had 100 shares of stock prior to the reverse split would have 22 shares after the split.

Akanda (AKAN) raised $20 million in an IPO on Wednesday, February 16th 2022. The company issued 4,000,000 shares at a price of $4.00-$6.00 per share.

Shares of AKAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akanda investors own include Pacific Biosciences of California (PACB), Tilray Brands (TLRY), Recursion Pharmaceuticals (RXRX), Editas Medicine (EDIT), SoundHound AI (SOUN), Mobile-health Network Solutions (MNDR) and Ginkgo Bioworks (DNA).

Company Calendar

Today
5/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AKAN
CIK
1888014
Fax
N/A
Employees
110
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$840 thousand
Price / Sales
18.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$210.79 per share
Price / Book
0.14

Miscellaneous

Outstanding Shares
530,000
Free Float
425,000
Market Cap
$15.20 million
Optionable
Not Optionable
Beta
14.49
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:AKAN) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners